Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma

NCT00808639 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Bladder Cancer
Muscle-invasive Bladder Cancer

Interventions

DRUG: Methotrexate
DRUG: Doxorubicin
DRUG: vinblastine
DRUG: cisplatin
DRUG: Pegfilgrastim

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]
[object Object]